91 related articles for article (PubMed ID: 22445599)
1. Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome.
Omiya T; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Hiratsuka A; Fukuda M; Yoshida M; Matsuzaki M
J Cardiol; 2012 Jul; 60(1):47-54. PubMed ID: 22445599
[TBL] [Abstract][Full Text] [Related]
2. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome.
Watanabe A; Fukushima Kusano K; Morita H; Miura D; Sumida W; Hiramatsu S; Banba K; Nishii N; Nagase S; Nakamura K; Sakuragi S; Ohe T
Eur Heart J; 2006 Jul; 27(13):1579-83. PubMed ID: 16760208
[TBL] [Abstract][Full Text] [Related]
3. Effects of isoproterenol infusion on the ST segment and r' of the QRS complex in the right precordial leads of the Brugada-type electrocardiogram pattern.
Kataoka H
J Cardiol; 2013 Apr; 61(4):312. PubMed ID: 23465866
[No Abstract] [Full Text] [Related]
4. Effects of isoproterenol infusion on the ST segment and r of the QRS complex in the right precordial leads of the Brugada-type electrocardiogram pattern--author's reply.
Shimizu A; Omiya T; Ueyama T; Yoshiga Y; Doi M; Hiratsuka A; Fukuda M; Yoshida M; Matsuzaki M; Yano M
J Cardiol; 2013 Apr; 61(4):312-3. PubMed ID: 23498027
[No Abstract] [Full Text] [Related]
5. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation.
Ohgo T; Okamura H; Noda T; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Ohe T; Shimizu W
Heart Rhythm; 2007 Jun; 4(6):695-700. PubMed ID: 17556186
[TBL] [Abstract][Full Text] [Related]
6. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
[TBL] [Abstract][Full Text] [Related]
7. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
[TBL] [Abstract][Full Text] [Related]
8. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome.
Nakagawa E; Takagi M; Tatsumi H; Yoshiyama M
Circ J; 2008 Jun; 72(6):1025-9. PubMed ID: 18503235
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
[TBL] [Abstract][Full Text] [Related]
10. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
Belhassen B; Glick A; Viskin S
Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
[TBL] [Abstract][Full Text] [Related]
11. What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
Sugi N; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Ohno M; Yoshida M; Matsuzaki M
J Cardiol; 2010 Jul; 56(1):35-43. PubMed ID: 20350514
[TBL] [Abstract][Full Text] [Related]
12. A Case of J Wave Syndrome Due to Severe Hypercalcemia with Ventricular Fibrillation Storm and Successful Treatment of Isoproterenol Infusion.
Shiozaki M; Sumiyoshi M; Tabuchi H; Hayashi H; Tamura H; Inoue K; Minamino T
Int Heart J; 2021; 62(4):924-926. PubMed ID: 34334584
[TBL] [Abstract][Full Text] [Related]
13. [Time distribution of ventricular arrhythmias in patients with Brugada syndrome].
Yang B; Cao KJ; Shan QJ; Xia Y; Tu J; Chen ML; Zou JG; Xu DJ; Li KL; Chen C
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):429-32. PubMed ID: 16776958
[TBL] [Abstract][Full Text] [Related]
14. Isoprenaline and quinidine to calm Brugada VF storm.
Furniss G
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22891011
[TBL] [Abstract][Full Text] [Related]
15. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome.
Take Y; Morita H; Wu J; Nagase S; Morita S; Toh N; Nishii N; Nakamura K; Kusano KF; Ohe T; Ito H; Zipes DP
Heart Rhythm; 2011 Jul; 8(7):1014-21. PubMed ID: 21315838
[TBL] [Abstract][Full Text] [Related]
18. The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia.
Komiya N; Seto S; Nakao K; Yano K
Pacing Clin Electrophysiol; 2005 Jul; 28(7):680-4. PubMed ID: 16008804
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patients.
Hiratsuka A; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Yoshida M; Fukuda M; Matsuzaki M
Circ J; 2012; 76(3):624-33. PubMed ID: 22251750
[TBL] [Abstract][Full Text] [Related]
20. [Electrical storm in Brugada syndrome successfully treated with isoproterenol. Report of a case].
Vega J; Enríquez A; Vergara I; Frangini P; Baeza M; Millapán I; González R
Rev Med Chil; 2013 Oct; 141(10):1340-3. PubMed ID: 24522365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
